Role of Bcl-2/adenovirus E1B 19 kDa-interacting protein 3 in myocardial cells in diabetes

Experimental and Therapeutic Medicine

Volumn 10, Issue 1, 2015, Pages 67-73

  Zhou, Wenzhong ^a   Yang, Jian ^a   Zhang, Di ^a   Li, Fengyin ^a   Li, Guo ^a   Gu, Yanyun ^a   Luo, Min ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Bcl 2 adenovirus E1B 19 kDa interacting protein 3; Diabetes; Diabetic cardiomyopathy

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE 1 B; CARNITINE PALMITOYLTRANSFERASE I; CREATINE KINASE; CYTOCHROME C OXIDASE; GELATINASE B; MITOCHONDRIAL PROTEIN; PLASMID VECTOR; PROTEIN BNIP3; SMALL INTERFERING RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GENE CONTROL; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; INFLAMMATION; MICROARRAY ANALYSIS; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NEWBORN; NONHUMAN; OXIDATIVE PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROTEIN ISOLATION; RAT; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

EID: 84929622608     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2439     Document Type: Article

References (35)

1. Guariguata L: By the numbers: new estimates from the IDF Diabetes Atlas Update for 2012. Diabetes Res Clin Pract 98: 524-525, 2012.
2. Xu Y, Wang L, He J, et al; 2010 China Noncommunicable Disease Surveillance Group: Prevalence and control of diabetes in Chinese adults. JAMA 310: 948-959, 2013.
3. Fox CS, Coady S, Sorlie PD, et al: Trends in cardiovascular complications of diabetes. JAMA 292: 2495-2499, 2004.
4. No authors listed: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837-853, 1998.
5. Poirier P, Bogaty P, Garneau C, Marois L and Dumesnil JG: Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24: 5-10, 2001.
6. Bertoni AG, Tsai A, Kasper EK and Brancati FL: Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care 26: 2791-2795, 2003.
7. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW and Grishman A: New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30: 595-602, 1972.
8. Fonarow GC and Srikanthan P: Diabetic cardiomyopathy. Endocrinol Metab Clin North Am 35: 575-599, 2006.
9. Young ME, McNulty P and Taegtmeyer H: Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 105: 1861-1870, 2002.
10. Boudina S and Abel ED: Diabetic cardiomyopathy revisited. Circulation 115: 3213-3223, 2007.
11. Crow MT, Mani K, Nam YJ and Kitsis RN: The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 95: 957-970, 2004.
12. Modrak J: Collagen metabolism in the myocardium from streptozotocin-diabetic rats. Diabetes 29: 547-550, 1980.
13. Shimizu M, Umeda K, Sugihara N, et al: Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol 46: 32-36, 1993.
14. Neubauer S: The failing heart - an engine out of fuel. N Engl J Med 356: 1140-1151, 2007.
15. Crow MT: Hypoxia, BNip3 proteins, and the mitochondrial death pathway in cardiomyocytes. Circ Res 91: 183-185, 2002.
16. Yasuda M, Theodorakis P, Subramanian T and Chinnadurai G: Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. J Biol Chem 273: 12415-12421, 1998.
17. Lomonosova E and Chinnadurai G: BH3-only proteins in apoptosis and beyond: an overview. Oncogene 27 Suppl 1: S2-S19, 2008.
18. Sulistijo ES, Jaszewski TM and MacKenzie KR: Sequence-specific dimerization of the transmembrane domain of the ‘BH3-only’ protein BNIP3 in membranes and detergent. J Biol Chem 278: 51950-51956, 2003.
19. Bocharov EV, Pustovalova YE, Pavlov KV, et al: Unique dimeric structure of BNip3 transmembrane domain suggests membrane permeabilization as a cell death trigger. J Biol Chem 282: 16256-16266, 2007.
20. Ray R, Chen G, Vande Velde C, et al: BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J Biol Chem 275: 1439-1448, 2000.
21. Guo K, Searfoss G, Krolikowski D, et al: Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ 8: 367-376, 2001.
22. Regula KM, Ens K and Kirshenbaum LA: Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ Res 91: 226-231, 2002.
23. Diwan A, Krenz M, Syed FM, et al: Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. J Clin Invest 117: 2825-2833, 2007.
24. Zhang F, Li G, Ding W, et al: Screening and analysis of early cardiopathology-related gene in type 2 diabetes mellitus. Zhonghua Nei Ke Za Zhi 41: 530-533, 2002 (In Chinese).
25. Zhang F, Ye C, Li G, et al: The rat model of type 2 diabetic mellitus and its glycometabolism characters. Exp Anim 52: 401-407, 2003.
26. Althaus J, Bernaudin M, Petit E, Toutain J, Touzani O and Rami A: Expression of the gene encoding the pro-apoptotic BNIP3 protein and stimulation of hypoxia-inducible factor-1alpha (HIF-1alpha) protein following focal cerebral ischemia in rats. Neurochem Int 48: 687-695, 2006.
27. Papandreou I, Krishna C, Kaper F, Cai D, Giaccia AJ and Denko NC: Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. Cancer Res 65: 3171-3178, 2005.
28. Kim JY, Cho JJ, Ha J and Park JH: The carboxy terminal C-tail of BNip3 is crucial in induction of mitochondrial permeability transition in isolated mitochondria. Arch Biochem Biophys 398: 147-152, 2002.
29. Vande Velde C, Cizeau J, Dubik D, et al: BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 20: 5454-5468, 2000. 30. Minhas KM, Saraiva RM, Schuleri KH, et al: Xanthine oxidore
30. ductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy. Circ Res 98: 271-279, 2006.
31. Duncan JG: Mitochondrial dysfunction in diabetic cardiomyopathy. Biochim Biophys Acta 1813: 1351-1359, 2011.
32. Spinale FG: Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87: 1285-1342, 2007.
33. Youle RJ and van der Bliek AM: Mitochondrial fission, fusion, and stress. Science 337: 1062-1065, 2012.
34. Yu T, Sheu SS, Robotham JL and Yoon Y: Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc Res 79: 341-351, 2008.
35. Ungar I, Gilbert M, Siegel A, Blain JM and Bing RJ: Studies on myocardial metabolism. IV. Myocardial metabolism in diabetes. Am J Med 18: 385-396, 1955.